| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |